Literature DB >> 10343135

Fragmentation pattern of mucins in normal and diseased gastric mucosae: a glycoprotein fractionates with gastric mucins purified from mucosal scrapings of cancer and peptic ulcer patients.

A S Mall1, H A McLeod, R Hickman, D Kahn, D M Dent.   

Abstract

BACKGROUND/AIMS: Gastric cancer, a fatal malignancy, is prevalent in the Western Cape region of South Africa. The aim of this study was a biochemical characterisation of gastric mucins in this disease, compared with gastric ulceration and controls from transplant donors.
METHODS: Mucins were extracted in a denaturing medium (to prevent endogenous proteolysis) and purified by caesium chloride density gradient ultracentrifugation. Analysis of mucin was by gel filtration, SDS-PAGE and Western blotting methods.
RESULTS: All samples of mucin when analysed by gel filtration were found to contain polymeric glycoprotein together with varying amounts of lower-molecular-weight glycoprotein. SDS-PAGE and Western blot analysis showed that diseased stomachs had glycopeptides of a wider range in size and antigenicity with a greater number of smaller fragments immunoreactive to monoclonal antibodies 2-12M1 and 9-13M1. We identified by SDS-PAGE a glycoprotein which co-fractionates in a caesium chloride density gradient with mucins isolated from gastrectomy specimens resected for carcinoma and peptic ulceration and which was absent from mucins of the transplant donor control group. This neuraminidase-sensitive glycoprotein resisted dissociation from mucin during purification in a 3.5 M CsCl density gradient but was partially separable by Sepharose 2B gel chromatography and heat treatment (100 degrees C, 2.0 min) in SDS. Chemical analysis of the glycoprotein by HPLC favours it being an N-linked glycoprotein. Its non-ideal electrophoretic properties make its exact size estimation difficult and we ascribe to it a broad size range of Mr approximately 55-65 kD.
CONCLUSION: We conclude that mucins from diseased stomachs were more degraded than those from donors and that the diseased mucosa reproducibly secretes a Mr approximately 55-65 kD glycoprotein, the role of which needs to be established.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10343135     DOI: 10.1159/000007662

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  9 in total

Review 1.  Small bowel review: Normal physiology, part 1.

Authors:  Alan B R Thomson; Laurie Drozdowski; Claudiu Iordache; Ben K A Thomson; Severine Vermeire; M Tom Clandinin; Gary Wild
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

2.  Diagnostic accuracy of induced sputum LAM ELISA for tuberculosis diagnosis in sputum-scarce patients.

Authors:  J G Peter; T J Cashmore; R Meldau; G Theron; R van Zyl-Smit; K Dheda
Journal:  Int J Tuberc Lung Dis       Date:  2012-06-14       Impact factor: 2.373

Review 3.  Review of the adenocarcinoma cell surface receptor for human alpha-fetoprotein; proposed identification of a widespread mucin as the tumor cell receptor.

Authors:  G J Mizejewski
Journal:  Tumour Biol       Date:  2013-02-28

4.  Immunohistochemical and biochemical characterization of mucin in pseudomyxoma peritonei: a case study.

Authors:  Anwar S Mall; Zoe Lotz; Marilyn Tyler; Paul Goldberg; Jeronimo Rodrigues; Delawir Kahn; Nthato Chirwa; Dhirendra Govender
Journal:  Case Rep Gastroenterol       Date:  2011-01-07

5.  A 40-50kDa Glycoprotein Associated with Mucus is Identified as α-1-Acid Glycoprotein in Carcinoma of the Stomach.

Authors:  Nthato Chirwa; Dhirendra Govender; Bongani Ndimba; Zoe Lotz; Marilyn Tyler; Eugenio Panieri; Delawir Kahn; Anwar S Mall
Journal:  J Cancer       Date:  2012-02-09       Impact factor: 4.207

6.  The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of Human Immunodeficiency Virus type 1 in an inhibition assay.

Authors:  Habtom H Habte; Anwar S Mall; Corena de Beer; Zoë E Lotz; Delawir Kahn
Journal:  Virol J       Date:  2006-11-24       Impact factor: 4.099

7.  The role of crude saliva and purified salivary mucins in the inhibition of the Human Immunodeficiency Virus type 1.

Authors:  Julia Peacocke; Zoe Lotz; Corena de Beer; Paul Roux; Anwar S Mall
Journal:  Virol J       Date:  2012-08-28       Impact factor: 4.099

8.  The characterisation of mucin in a mature ovarian teratoma occurring in an eight year old patient.

Authors:  Anwar Suleman Mall; Marilyn Tyler; Zoe Lotz; Alan Davidson; Jerry Rodrigues; George van der Watt; Delawir Kahn; Dhirendra Govender
Journal:  Int J Med Sci       Date:  2007-04-10       Impact factor: 3.738

Review 9.  Mucus and Mucins: do they have a role in the inhibition of the human immunodeficiency virus?

Authors:  Anwar Suleman Mall; Habtom Habte; Yolanda Mthembu; Julia Peacocke; Corena de Beer
Journal:  Virol J       Date:  2017-10-06       Impact factor: 4.099

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.